Intersectional Stigma Reduction for Tajik Migrants Who Inject Drugs
减少注射毒品的塔吉克移民的跨部门耻辱
基本信息
- 批准号:10755435
- 负责人:
- 金额:$ 17.81万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-08-04 至 2026-03-31
- 项目状态:未结题
- 来源:
- 关键词:AIDS preventionAcquired Immunodeficiency SyndromeAddressAdoptedAdoptionAdverse effectsAffectAsianAttitudeBehaviorBehavioralBeliefCentral AsiaCommunitiesCountryDiffusionDrug usageEducationEnvironmentEpidemicFamilyFeedbackFocus GroupsFriendsFutureGoalsHIVHIV InfectionsHIV SeropositivityHIV riskHealthHealth PersonnelHuman immunodeficiency virus testInjecting drug userInterventionInterviewLabor MigrationsLanguageLeadershipMethodsMigrantMigrant WorkersModelingModificationMoscowMovementOutcome MeasurePersonal SatisfactionPharmaceutical PreparationsPopulationPreventionProcess MeasureResearchRiskRisk BehaviorsRussiaServicesSocial NetworkSocietiesStigmatizationTajikistanTestingTrainingTrustUnemploymentWorkacceptability and feasibilitydesignefficacy testingexperiencehigh riskillicit drug useinnovationinsightmarginalizationmembernegative affectnon-drugpeerpoor health outcomeprototyperecruitsocialsocial culturesocial stigmasocioeconomicstransmission processtreatment services
项目摘要
Project Summary
Labor migration is a major contributor to fueling the global AIDS epidemic and also the movement of HIV
across country borders and populations. Migrants who inject drugs while in a host country are at especially
high risk. Tajikistan, a small country in Central Asia, exports more than a million temporary labor migrants
annually, many of whom inject drugs. These migrants are highly subject to the negative effects of intersectional
stigma within Russia's cultural and socio-economic environment due to being both a migrant worker and a
person who injects drugs (PWID). In addition, they are subject to extensive censure and marginalization from
their non-drug-using Tajik peers in the close-knit diaspora communities in which they reside, especially if they
acquire HIV. The adverse effects of stigmatization on those who experience it are well documented. The
intersection of stigmatized identities as migrants and people who inject drugs (PWID), along with stigma
associated with HIV infection, contributes to HIV risk behavior, poses as a barrier to accessing HIV testing and
other prevention/treatment services, and results in poorer health outcomes for those living with HIV.
The proposed study will investigate the character of stigma in the Moscow Tajik migrant community,
and the effects of multiple intersecting forms of stigma on the health and well-being of Tajik labor migrants who
inject drugs while living in Moscow (Aim 1). We will use the insight and findings gained through this formative
research to develop an innovative intervention specifically designed to counter the negative effects of drug-
related stigma within the Tajik migrant community that can affect HIV risk behavior and prevention among Tajik
migrants in Moscow who inject drugs (Aim 2). The Stigma Reduction Intervention Approach Via Leaders of
Diaspora (SRI-AVLOD) intervention will draw on the strengths of close-knit Tajik diaspora communities in
which new norms and behaviors can be effectively diffused and promoted within and across migrant social
networks if endorsed by leaders whom they trust. SRI-AVLOD is designed to recruit and train Tajik diaspora
community leaders as agents of change and open up conversation within the Moscow Tajik community about
the effects of drug and HIV-related stigma, to reduce stigmatizing beliefs and actions that negatively affect HIV
risk behavior and prevention among community members who inject drugs. After developing a working
prototype, we will deliver the intervention to small groups of Tajik migrant community leaders to assess its
feasibility and acceptability, and need for further modifications (Aim 3).
In future work we will deliver and test the efficacy of the SRI-AVLOD model in changing drug-related
stigma and stigmatizing beliefs, behavior, and consequences at all levels (community, leadership, PWID)
within the Tajik diaspora community and its positive effects in reducing HIV risk behavior and increasing the
adoption of HIV prevention methods and services among its Tajik members who inject drugs.
项目摘要
劳动力迁移是助长全球艾滋病流行和艾滋病毒传播的主要因素
跨越国界和人口。在东道国注射毒品的移徙者特别容易受到
高风险。塔吉克斯坦,一个中亚小国,输出了一百多万临时劳动力移民
每年,其中许多人注射毒品。这些移民极易受到跨部门移民的负面影响。
在俄罗斯的文化和社会经济环境中,由于既是移民工人又是
注射毒品的人(PWID)此外,他们还受到广泛的谴责和边缘化,
他们居住在关系密切的侨民社区中的不吸毒的塔吉克同龄人,特别是如果他们
感染艾滋病毒。污名化对遭受污名化者的不利影响已有大量文献记载。的
作为移民和注射毒品者的污名化身份的交集,沿着污名化
与艾滋病毒感染有关,有助于艾滋病毒的危险行为,成为获得艾滋病毒检测的障碍,
其他预防/治疗服务,并导致艾滋病毒感染者的健康结果较差。
拟议的研究将调查莫斯科塔吉克移民社区的耻辱特征,
以及多种交叉形式的耻辱对塔吉克劳工移民的健康和福祉的影响,
在莫斯科居住期间注射毒品(目标1)。我们将利用这次形成性的会议所获得的见解和发现,
研究开发一种创新的干预措施,专门用于对抗药物的负面影响,
塔吉克移民社区内可能影响塔吉克人艾滋病毒风险行为和预防的相关污名
莫斯科注射毒品的移民(目标2)。减少污名干预方法,通过领导人
散居国外的塔吉克人(SRI-AVLOD)的干预措施将利用塔吉克散居国外的塔吉克人社区的力量,
哪些新的规范和行为可以在移民社会内部和之间有效地传播和推广
网络,如果得到他们信任的领导人的认可。SRI-AVLOD旨在招募和培训塔吉克侨民
社区领导人作为变革的推动者,并在莫斯科塔吉克社区内展开对话,
毒品和艾滋病毒相关污名化的影响,减少对艾滋病毒产生负面影响的污名化观念和行动
注射毒品的社区成员的危险行为和预防。在开发了一个工作
原型,我们将提供干预的塔吉克移民社区领袖小组,以评估其
可行性和可接受性,以及需要进一步修改(目标3)。
在未来的工作中,我们将提供并测试SRI-AVLOD模型在改变药物相关性方面的有效性。
污名化和污名化的信念,行为和后果在所有层面(社区,领导,PWID)
在塔吉克散居社区内的艾滋病毒感染及其在减少艾滋病毒危险行为和增加
在注射毒品的塔吉克成员中采用艾滋病毒预防方法和服务。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Mahbat Bahromov其他文献
Mahbat Bahromov的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Mahbat Bahromov', 18)}}的其他基金
Scaling-Up Stepped Care for Women's Mental Health in Primary Care in an LMIC
在中低收入国家的初级保健中扩大对妇女心理健康的分级护理
- 批准号:
10477040 - 财政年份:2019
- 资助金额:
$ 17.81万 - 项目类别:
Scaling-Up Stepped Care for Women's Mental Health in Primary Care in an LMIC
在中低收入国家的初级保健中扩大对妇女心理健康的分级护理
- 批准号:
10247042 - 财政年份:2019
- 资助金额:
$ 17.81万 - 项目类别:
Scaling-Up Stepped Care for Women's Mental Health in Primary Care in an LMIC
在中低收入国家的初级保健中扩大对妇女心理健康的分级护理
- 批准号:
10676331 - 财政年份:2019
- 资助金额:
$ 17.81万 - 项目类别:
Scaling-Up Stepped Care for Women's Mental Health in Primary Care in an LMIC
在中低收入国家的初级保健中扩大对妇女心理健康的分级护理
- 批准号:
10001626 - 财政年份:2019
- 资助金额:
$ 17.81万 - 项目类别:
相似海外基金
RESEARCH SUPPORT SERVICES FOR THE DIVISION OF ACQUIRED IMMUNODEFICIENCY SYNDROME
获得性免疫缺陷综合症分类的研究支持服务
- 批准号:
10219039 - 财政年份:2020
- 资助金额:
$ 17.81万 - 项目类别:
RESEARCH SUPPORT SERVICES FOR THE DIVISION OF ACQUIRED IMMUNODEFICIENCY SYNDROME
获得性免疫缺陷综合症分类的研究支持服务
- 批准号:
9981476 - 财政年份:2019
- 资助金额:
$ 17.81万 - 项目类别:
IGF::OT::IGF RESEARCH SUPPORT SERVICES FOR THE DIVISION OF ACQUIRED IMMUNODEFICIENCY SYNDROME
IGF::OT::IGF 针对获得性免疫缺陷综合症分类的研究支持服务
- 批准号:
9364184 - 财政年份:2016
- 资助金额:
$ 17.81万 - 项目类别:
Human Immunodeficiency Virus (HIV) and Acquired Immunodeficiency Syndrome (AIDS) in Saskatchewan- Where are we now and what does the future hold?
萨斯喀彻温省的人类免疫缺陷病毒(HIV)和获得性免疫缺陷综合症(艾滋病)——我们现在在哪里以及未来会怎样?
- 批准号:
236932 - 财政年份:2011
- 资助金额:
$ 17.81万 - 项目类别:
Miscellaneous Programs
ACQUIRED IMMUNODEFICIENCY SYNDROME RESEARCH REVIEW COMMI
获得性免疫缺陷综合症研究审查委员会
- 批准号:
3554155 - 财政年份:1991
- 资助金额:
$ 17.81万 - 项目类别:
ACQUIRED IMMUNODEFICIENCY SYNDROME RESEARCH REVIEW COMMI
获得性免疫缺陷综合症研究审查委员会
- 批准号:
3554156 - 财政年份:1991
- 资助金额:
$ 17.81万 - 项目类别:
ACQUIRED IMMUNODEFICIENCY SYNDROME RESEARCH REVIEW
获得性免疫缺陷综合症研究综述
- 批准号:
2063342 - 财政年份:1991
- 资助金额:
$ 17.81万 - 项目类别:














{{item.name}}会员




